Hu­mani­gen de­clares win in se­vere Covid-19, de­liv­er­ing much-need­ed pan­dem­ic weapon and vault­ing ahead on post-Shkre­li turn­around

Hu­mani­gen, the one-time Mar­tin Shkre­li-run biotech, an­nounced that its an­ti­body helped keep pa­tients with Covid-19 off ven­ti­la­tion in a Phase III tri­al, po­ten­tial­ly giv­ing doc­tors …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER